| scholarly article | Q13442814 |
| P2093 | author name string | Colin P Doherty | |
| Colm Bergin | |||
| Janice Redmond | |||
| Patricia H McNamara | |||
| Robert Coen | |||
| P2860 | cites work | Cognitive neuropsychology of HIV-associated neurocognitive disorders | Q22252615 |
| Neurocognitive impairment and psychiatric comorbidity in well-controlled human immunodeficiency virus-infected Thais from the 2NN Cohort Study. | Q50588505 | ||
| Working memory performance predicts subjective cognitive complaints in HIV infection. | Q52011416 | ||
| Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors | Q57005738 | ||
| HIV-associated neurologic disease incidence changes:: Multicenter AIDS Cohort Study, 1990-1998 | Q57446072 | ||
| An Evaluation of Neurocognitive Status and Markers of Immune Activation as Predictors of Time to Death in Advanced HIV Infection | Q61876438 | ||
| Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning | Q73389284 | ||
| Evaluating anxiety and depression in HIV-infected patients | Q77955127 | ||
| HIV-associated cognitive impairment before and after the advent of combination therapy | Q95796528 | ||
| The hospital anxiety and depression scale | Q27860968 | ||
| Effects of alcohol and HIV infection on the central nervous system. | Q30681805 | ||
| Depression symptoms and cognitive function among individuals with advanced HIV infection initiating HAART in Uganda | Q33600252 | ||
| Neurobehavioral effects of human immunodeficiency virus infection among former plasma donors in rural China | Q33927844 | ||
| The effects of benzodiazepines on cognition. | Q33985695 | ||
| Wording effects and the factor structure of the Hospital Anxiety & Depression Scale in HIV/AIDS patients on antiretroviral treatment in South Africa | Q34247107 | ||
| Screening for neurocognitive impairment, depression, and anxiety in HIV-infected patients in Western Europe and Canada. | Q34320963 | ||
| HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study | Q34370880 | ||
| Cognitive impairment in older HIV-1-seropositive individuals: prevalence and potential mechanisms | Q34421694 | ||
| Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study | Q34455156 | ||
| Depressive disorders in Europe: prevalence figures from the ODIN study | Q34518032 | ||
| The epidemiology of human immunodeficiency virus-associated neurological disease in the era of highly active antiretroviral therapy | Q35030103 | ||
| The neurology of HIV infection | Q35576508 | ||
| Human immunodeficiency virus-associated neurocognitive disorder: pathophysiology in relation to drug addiction | Q37702353 | ||
| Prevalence and correlates of generalized anxiety disorder in a national sample of older adults | Q39268800 | ||
| The impact of HIV-associated neuropsychological impairment on everyday functioning | Q40509922 | ||
| HIV infection and dementia in older adults | Q44185197 | ||
| The prevalence and incidence of neurocognitive impairment in the HAART era. | Q44520627 | ||
| The effect of previous alcohol abuse on cognitive function in HIV infection | Q44750280 | ||
| Lowest ever CD4 lymphocyte count (CD4 nadir) as a predictor of current cognitive and neurological status in human immunodeficiency virus type 1 infection--The Hawaii Aging with HIV Cohort | Q45181283 | ||
| Neurocognitive functioning and HAART in HIV and hepatitis C virus co-infection | Q45414097 | ||
| Clinical validation of the NeuroScreen | Q46473380 | ||
| Neurologic disorders are prevalent in HIV-positive outpatients in the Asia-Pacific region | Q46509441 | ||
| The effect of African-American acculturation on neuropsychological test performance in normal and HIV-positive individuals. The HIV Neurobehavioral Research Center (HNRC) Group. | Q46897551 | ||
| Characterization of HIV-Associated Neurocognitive Disorders among individuals starting antiretroviral therapy in South Africa | Q46911957 | ||
| Prevalence of non-confounded HIV-associated neurocognitive impairment in the context of plasma HIV RNA suppression. | Q48889959 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | cognitive dysfunction | Q57859955 |
| P304 | page(s) | ofw242 | |
| P577 | publication date | 2016-12-27 | |
| P1433 | published in | Open Forum Infectious Diseases | Q27725953 |
| P1476 | title | A High Prevalence Rate of a Positive Screen for Cognitive Impairment in Patients With Human Immunodeficiency Virus Attending an Irish Clinic | |
| P478 | volume | 4 |
| Q51762497 | Global HIV neurology: a comprehensive review. |
| Q64082246 | High prevalence of neurocognitive disorders observed among adult people living with HIV/AIDS in Southern Ethiopia: A cross-sectional study |
| Q64903543 | Seizures in HIV: The case for special consideration. |
| Q53075373 | The Aging Brain With HIV Infection: Effects of Alcoholism or Hepatitis C Comorbidity. |
Search more.